Skip to content
10-Q

Quarterly Report

TAXUS PHARMACEUTICALS HOLDINGS, INC.

0001213900-18-004766

← back to feed
Filed
Apr 20, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2018 · Dec 31, 2017 81.5M sh
Operating Cash Flow Q2 2018 · Dec 31, 2017 −$28.02K
Cash And Equivalents Q2 2018 · Dec 31, 2017 $5.84K
Cash And Equivalents Q2 2018 · Jun 30, 2017 $5.86K
Stockholders Equity Q2 2018 · Dec 31, 2017 −$41.18K
Stockholders Equity Q2 2018 · Jun 30, 2017 −$53.66K
Current Liabilities Q2 2018 · Dec 31, 2017 $47.02K
Current Liabilities Q2 2018 · Jun 30, 2017 $62.52K
Current Assets Q2 2018 · Dec 31, 2017 $5.84K
Current Assets Q2 2018 · Jun 30, 2017 $5.86K
Total Assets Q2 2018 · Dec 31, 2017 $5.84K
Total Assets Q2 2018 · Jun 30, 2017 $8.86K
Sga Expense Q2 2018 · Dec 31, 2017 $4K
Sga Expense Q2 2018 · Dec 31, 2017 $16.02K
Net Income Q2 2018 · Dec 31, 2017 −$4K
Net Income Q2 2018 · Dec 31, 2017 −$15.52K
Gross Profit Q2 2018 · Dec 31, 2017 $500
Revenue Q2 2018 · Dec 31, 2017 $500